Cargando…

“Ideal” parathyroid hormone in erythropoietin‐stimulating agents‐resistant anemia

Erythropoietin‐stimulating agents (ESAs) have revolutionized anemia treatment in end‐stage renal disease (ESRD), but ESA resistance is increasingly identified. Secondary hyperparathyroidism (SHP) is one cause of ESA resistance. We describe a patient with ESA‐resistant, transfusion‐dependent anemia a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashraf, Bilal, Bat, Taha, Weinberg, Olga K., Moe, Orson W., Ibrahim, Ibrahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Short Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176131/ https://www.ncbi.nlm.nih.gov/pubmed/35846199 http://dx.doi.org/10.1002/jha2.316

Ejemplares similares

Erythropoietin stimulating agents in the management of anemia of chronic kidney disease
por: Hayat, Amir, et al.
Publicado: (2008)

Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)

Effect of erythropoietin-stimulating agent on uremic inflammation
por: Tanaka, Yuri, et al.
Publicado: (2012)

Impact of inflammation on anemia of hemodialysis patients who were under treatment of recombinant human erythropoietin
por: Rafiean-Kopaie, Mahmoud, et al.
Publicado: (2013)

Protocol of a randomized controlled trial of an erythropoietin stimulating agent decision aid for anemia treatment in kidney disease
por: Beach, Lauren B., et al.
Publicado: (2016)

Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: Is it feasible?
por: Gabutti, Luca, et al.
Publicado: (2011)

Significant association between parathyroid hormone and uric acid level in men
por: Chin, Kok-Yong, et al.
Publicado: (2015)

Model of the complex of Parathyroid hormone-2 receptor and Tuberoinfundibular peptide of 39 residues
por: Abraham-Nordling, Mirna, et al.
Publicado: (2010)

The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection
por: Hu, Ming-Chang, et al.
Publicado: (2013)

The Levels of Hepcidin and Erythropoietin in Pregnant Women with Anemia of Various Geneses
por: Vazenmiller, Dmitriy, et al.
Publicado: (2018)

Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction
por: Debeljak, Nataša, et al.
Publicado: (2014)

Treatment of Anemia in Kidney Disease: Beyond Erythropoietin
por: Wish, Jay B.
Publicado: (2021)

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer
por: Aapro, M, et al.
Publicado: (2012)

Scaling Pharmacodynamics from Rats to Humans to Support Erythropoietin and Romiplostim Combination Therapy to Treat Erythropoietin-Resistant Anemia
por: Fan, Xiaoqing, et al.
Publicado: (2023)

A Case of Ovarian Clear Cell Carcinoma Simultaneously Producing Parathyroid Hormone-related Protein and Granulocyte Colony-Stimulating Factor
por: Futagami, Masayuki, et al.
Publicado: (2010)

Immature Platelet Fraction as a Biomarker for Disease Severity in Pediatric Respiratory Coronavirus Disease 2019
por: Lee, Nicholas C.J., et al.
Publicado: (2022)

The relationship between anemia and accommodative esotropia in children
por: Turgut, Fethiye Gulden, et al.
Publicado: (2013)

Myelofibrosis-Induced Erythropoietin-Resistant Anemia Due to Severe Refractory Hyperparathyroidism
por: Sethi, Sidharth Kumar, et al.
Publicado: (2018)

Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation
por: Kimura, Shigemi, et al.
Publicado: (2014)

An Overview of Safety and Efficacy Between Hypoxia-Inducible Factor-Prolyl-Hydroxylase Inhibitors and Erythropoietin-Stimulating Agents in Treating Anemia in Chronic Kidney Disease Patients
por: Sonia, Shamsun Nahar, et al.
Publicado: (2023)

Erythropoietin in the intensive care unit: beyond treatment of anemia
por: Patel, Nimesh SA, et al.
Publicado: (2011)

Cost-effectiveness of continuous erythropoietin receptor activator in anemia
por: Schmid, Holger
Publicado: (2014)

Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology
por: Gowanlock, Zachary, et al.
Publicado: (2016)

Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin
por: Hanna, Ramy M., et al.
Publicado: (2020)

Erythropoietin in bone homeostasis—Implications for efficacious anemia therapy
por: Lappin, Katrina M., et al.
Publicado: (2021)

Serum Erythropoietin level in anemia of elderly with unclear etiology
por: Seong, Ju Yong, et al.
Publicado: (2023)

The Effect of Serum Ferritin Level on Gonadal, Prolactin, Thyroid Hormones, and Thyroid Stimulating Hormone in Adult Males with Sickle Cell Anemia
por: Mostafa, Gamal G, et al.
Publicado: (2020)

Testosterone priming increased growth hormone peak levels in the stimulation test and suppressed gonadotropin secretion in three Japanese adolescent boys
por: Sato, Takeshi, et al.
Publicado: (2020)

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Bae, Myoung Nam, et al.
Publicado: (2015)

Alcohol‐induced Wnt signaling inhibition during bone fracture healing is normalized by intermittent parathyroid hormone treatment
por: Kapania, Esha M., et al.
Publicado: (2020)

The Parathyroid Hormone-Related Protein/Parathyroid Hormone 1 Receptor Axis in Adipose Tissue
por: Izquierdo-Lahuerta, Adriana
Publicado: (2021)

Parathyroid Hormone-Related Protein/Parathyroid Hormone Receptor 1 Signaling in Cancer and Metastasis
por: Zhao, Yawei, et al.
Publicado: (2023)

Inhibition of Parathyroid Hormone Secretion by Caffeine in Human Parathyroid Cells
por: Lu, Ming, et al.
Publicado: (2013)

Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
por: Munie, Stephanie, et al.
Publicado: (2021)

Iron- and erythropoietin-resistant anemia in a spontaneous breast cancer mouse model
por: Bregolat, Nuria Fabregas, et al.
Publicado: (2022)

Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion
por: Centeno, Patricia P., et al.
Publicado: (2019)

Parathyroid hormone and vitamin D.
por: Harrison, H. E.
Publicado: (1966)

Parathyroid Hormone Signaling in Osteocytes
por: Wein, Marc N
Publicado: (2017)

Anemia and blood transfusion in the critically ill patient: role of erythropoietin
por: Corwin, Howard L
Publicado: (2004)

The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions
por: Palazzuoli, Alberto, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m5rrh8cv1isr7laiavvffg30mg